TMPRSS11D and chronic myelogenous leukemia, BCR-ABL1 positive: To verify our findings, we examined HAT‐L4 expression in peripheral white blood cells (n = 7) and bone marrow cells (n = 6) from normal individuals, and bone marrow cells from AML (n = 60), CML (n = 17), ALL (n = 17), and CLL (n = 5) patients.